That COVID-19 rapid test detect antibodies developed so you have to had contracted COVID-19 in the first place and recover from it. If there is a cough signature for coronavirus such as SARS, COVID-19, etc, that's where this will benefit RAP's biomarket technology but I agree, it shouldn't be the priority of RAP right now.
- Forums
- ASX - By Stock
- RAP
- Telehealth on the rise
Telehealth on the rise, page-2158
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 917 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)